0.11Open0.25Pre Close2 Volume510 Open Interest15.00Strike Price22.00Turnover88.18%IV14.18%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.11Extrinsic Value100Contract SizeAmericanOptions Type-0.2141Delta0.0757Gamma31.55Leverage Ratio-0.0241Theta-0.0025Rho-6.75Eff Leverage0.0127Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet